Posts in tag
annual report
“Lumpy” licensing lag hits AFT profits
Kiwi pharmaco behind Maxigesic sees net profits down 2/3 year-on-year but leadership remains upbeat about the future Lower licencing income and increased growth in spending were factors which saw the …
EBOS reports ‘solid growth’ in underlying earnings
Full-year highlights included signed agreement with Chemist Warehouse Group for exclusive wholesale distribution, and moving to 100% ownership of TWC – but PBS reforms are having an impact EBOS Group …